Sexual Medicine, published by Oxford University Press, is a leading open-access journal dedicated to advancing the field of sexual health and medicine since its inception in 2013. With an E-ISSN of 2050-1161, this journal provides a platform for high-quality research that spans multiple disciplines including Behavioral Neuroscience, Dermatology, Endocrinology, Psychiatry and Mental Health, and Reproductive Medicine. Notably, the journal has maintained a solid standing in its category quartiles, with rankings reflecting its significant impact in the fields of Urology (Rank #18/120, 85th Percentile) and Reproductive Medicine (Rank #25/90, 72nd Percentile), among others. The open-access model enhances accessibility to groundbreaking research, ensuring that knowledge is disseminated widely to researchers, healthcare professionals, and students alike. With a commitment to fostering a deeper understanding of the complexities surrounding sexual health, Sexual Medicine endeavors to provide critical insights and foster discussions that drive innovation and improvement in clinical practices. Discover more and stay updated on the latest findings in sexual health by engaging with this invaluable resource on a global scale.

Middle East Current Psychiatry (MECPsych), published by SpringerNature, is a prominent open-access journal dedicated to advancing the field of psychiatry and mental health in the Middle East and beyond. Since its establishment in 2011, MECPsych has aimed to disseminate high-quality research, reviews, and reports that capture recent developments in psychiatric science, clinical practice, and public health considerations in mental well-being. With an impact factor reflective of its growing influence and classified in the Q3 quartile for Psychiatry and Mental Health, the journal offers invaluable insights backed by rigorous peer review processes. Operating under an open access model since 2019, MECPsych ensures that its articles are freely accessible to a global readership, enhancing the visibility and application of research findings. As part of its ongoing commitment to enriching understanding in the field, MECPsych also encourages submissions that explore the unique cultural, societal, and economic factors influencing mental health across the region. This approach not only supports researchers, professionals, and students in their pursuit of knowledge but also fosters a collaborative dialogue among mental health stakeholders in the Middle East and around the world.

Therapeutic Advances in Psychopharmacology is a leading open-access journal published by SAGE Publications Ltd, focusing on the dynamic integration of pharmacological therapies and psychological health. Since its inception in 2011, this journal has made a significant impact on the fields of pharmacology and psychiatry, consistently earning a Q1 ranking in both categories as of 2023, reflecting its esteemed position within the scientific community. With an impressive Scopus rank placing it in the top 15% across relevant disciplines, the journal serves as a vital platform for researchers, professionals, and students eager to explore cutting-edge advancements in psychopharmacology. The open-access model, established in 2019, ensures that groundbreaking research is accessible to a wide audience, fostering collaboration and innovation in therapeutic strategies for mental health disorders. Through the dissemination of high-quality research and reviews, Therapeutic Advances in Psychopharmacology is committed to advancing understanding and practice within this critical field.

Current Opinion in Psychiatry is a premier journal published by Lippincott Williams & Wilkins, dedicated to the dynamic and evolving field of psychiatry and mental health. With a commendable impact factor and ranking 30th out of 567 in the Scopus database, this journal occupies a Q1 quartile position, reflecting its significance and influence within the academic community. Since its inception in 1988, Current Opinion in Psychiatry has aimed to provide critical reviews, leading research, and expert opinions that shape clinical practice and decision-making in psychiatry. While the journal is not open access, it continues to serve as an essential resource for researchers, clinicians, and students seeking insights into contemporary psychiatric challenges and advancements. With its ongoing commitment to high-quality content, the journal remains a vital platform for knowledge dissemination and dialog in the field.

BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.

PSYCHIATRIC ANNALS, published by SLACK INC, is a renowned journal dedicated to the dynamic field of psychiatry and mental health. With an ISSN of 0048-5713 and E-ISSN 1938-2456, this journal serves as a vital platform for the dissemination of innovative research and practices in psychiatry, seeking to enhance understanding and treatment of mental health disorders. Founded in 1974, it has survived numerous convergent years of publishing and continues to offer valuable insights for professionals and researchers alike, currently holding a Q4 category ranking in the Psychiatry and Mental Health field according to the 2023 category quartiles. Although it does not operate under an open access model, its contributions to medical literature are significant, as evidenced by its rankings in Scopus. PSYCHIATRIC ANNALS strives to foster collaboration and discussion among experts, thereby advancing mental health knowledge and practices, making it an essential resource for those committed to improving patient care and outcomes.

The Brazilian Journal of Psychiatry is a prominent peer-reviewed journal dedicated to advancing the field of psychiatry and mental health, published by the Associação Brasileira de Psiquiatria. With an impressive Q2 ranking in the Psychiatry and Mental Health category for 2023 and a Scopus rank of #130 out of 567, this journal serves as a vital resource for researchers, clinicians, and students alike. Since its transition to Open Access in 1999, it has aimed to disseminate high-quality research, innovative practices, and critical insights relevant to mental health in Brazil and beyond. The journal's focus spans various topics in psychiatry, aiming to bridge the gap between research and clinical application, making it essential reading for professionals and academicians committed to improving mental health outcomes. With a commitment to fostering scholarly discourse, the Brazilian Journal of Psychiatry not only enriches the academic landscape but also enhances the practice of psychiatry through its widespread accessibility and dedication to excellence in research.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE is a distinguished publication dedicated to advancing the understanding of psychiatric practice and mental health issues within a medical framework. Published by SAGE PUBLICATIONS INC, this journal has been a trusted source in the field since its inception, with its archives dating back to 1973. It offers a comprehensive exploration of psychiatric research, clinical studies, and theoretical advancements that seek to bridge the gap between psychiatry and general medicine. With an impact factor reflective of its quality and relevance, categorized in the Q3 quartile in Psychiatry and Mental Health, this journal stands as a vital resource for researchers, clinicians, and students alike. Although operating on a traditional subscription model, the extensive knowledge shared within its pages contributes significantly to ongoing discussions in psychiatric and mental health education and practice. As the field continually evolves, the INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE remains committed to fostering innovative and impactful scholarship that resonates with professionals navigating the complexities of mental health in clinical contexts.

JOURNAL OF PSYCHOSOMATIC RESEARCH, published by Pergamon-Elsevier Science Ltd, stands as a premier international forum dedicated to the integration of psychological and physical health. Established in 1956, this esteemed journal has maintained a high impact in the field, currently ranking in the Q1 category for both Clinical Psychology and Psychiatry and Mental Health as of 2023. With an impressive Scopus ranking of #37/311 in Clinical Psychology and #95/567 in Psychiatry and Mental Health, it caters to a wide audience of researchers, clinicians, and students interested in the complex interplay between psychosocial factors and physical health outcomes. The journal publishes a diverse array of original research, reviews, and clinical studies, providing valuable insights into psychosomatic medicine. While it currently does not offer open access options, its robust editorial standards ensure that each publication contributes significantly to advancing the field. As the journal converges into its 68th year, it continues to be at the forefront of psychosomatic research, instrumental in shaping evidence-based practices and enhancing patient care.

Rivista di Psichiatria, published by PENSIERO SCIENTIFICO EDITORE, stands as a significant contributor to the field of Psychiatry and Mental Health since its inception in 1975. With an ISSN of 0035-6484 and an E-ISSN of 2038-2502, this esteemed journal offers a platform for rigorous academic discourse and cutting-edge research, helping to shape contemporary psychiatric practices and theories. Currently holding a Q2 designation in Psychiatry and Mental Health based on the 2023 category quartiles, and ranking #197 out of 567 in Scopus, it reflects a commendable 65th percentile among its peers. The journal welcomes contributions that encompass a broad range of topics related to mental health, encouraging contributions from a multidisciplinary approach, which aids in its goal of advancing the understanding and application of psychiatric science. While it is a traditional journal without Open Access options, access to its valuable content can support researchers, clinicians, and students in their pursuit of knowledge and innovation within the field. Situated in Rome, Italy, at VIA SAN GIOVANNI VALDARNO 8, ROME 00138, the journal continues to enhance its rich legacy, promoting the exchange of ideas and fostering collaboration amongst practitioners and scholars alike.